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Endovascular tumor embolization as adjunctive therapy for head and neck cancers is evolv-
ing and has become an important part of the tools available for their treatment. Careful
study of tumor vascular anatomy and adhering to general principles of intra-arterial therapy
can prove this approach to be effective and safe. Various embolic materials are available
and can be suited for a given tumor and its vascular supply. This article aims to summarize
current methods and agents used in endovascular head and neck tumor embolization and
discuss important angiographic and treatment characteristics of selected common head
and neck tumors.
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INTRODUCTION
According to the National Cancer Institute, cancer of the head
and neck accounts for 3–5% of the total cancer incidence in the
US (National Cancer Institute, 2011). In 2005, there were 39,000
cases of head and neck cancers. Approximately 19,000 cases of
primary brain tumors are diagnosed annually in the US. Angiog-
raphy and intra-arterial embolization of a tumor contributes in
diagnosis, surgical planning, and treatment. Characterization of
angiographic features including vascular architecture and ﬂow
patterns can contribute to diagnosis. Angiography also provides
intricate evaluation of the tumor vascular supply and proxim-
ity of neighboring vessels that can be of great value in surgical
planning. Intra-arterial embolization is often adjunctive therapy
prior to surgical resection. Embolization and devascularization of
these tumors can reduce blood loss during surgical resection and
improve visualization of the surgical site. In patients who are not
candidates for surgical resection, intra-arterial embolization can
provide palliative therapy. Endovascular therapies have expanded
to include infusions of agents which disrupt the blood–brain bar-
rier that can be used to treat lymphomas, and local intra-arterial
chemotherapy infusion which can be utilized to treat squamous
cell cancers of the head and neck. The advent of targeted therapies
such as anti-bodies, nanoparticles, and gene vectors may herald
a new era of intra-arterial delivery of therapeutic agents to these
tumors.
PRINCIPLES OF ANGIOGRAPHY FOR HEAD AND NECK
TUMORS
Angiography in patients with head and neck tumors can provide
valuable diagnostic and treatment planning information. Careful
and exhaustive investigation of all possible tumor supply is impor-
tant for safe and effective therapy. A complete cerebral angiogram
is often necessary including dedicated injections of the internal
and external carotid arteries and vertebral arteries bilaterally. Ded-
icated cervical vessel angiograms may also be necessary depending
on tumor location. Tumor vascular supply and recruitment can
varywidely andbilateral supply is common,especially in tumors of
themidline neck, ethmoid bone, andmeningiomas. Superselective
micro-catheterization is often necessary for complete evaluation
of individual distal vessel supply and to assess for intra-tumoral
shunting. Presence of intra-tumoral shunting may increase the
risks of embolization. Additionally, close attention should be paid
to the presence of anastomoses between extra and intra-cranial
circulation or anastomoses to critical structures such as the eye or
vaso nervosum supplying various cranial nerves (Table 1).
ANGIOGRAPHIC FEATURES OF HEAD AND NECK TUMORS
Various angiographic features of head and neck tumors are impor-
tant in tumor characterization and treatment planning. The vas-
cular architecture can differ widely among tumors and charac-
terization can be helpful in diagnosis. Vascular supply may be
encasing, inﬁltrating, diffuse, focal, dense, patterned, or include
various other characterizations. The degree of vascularity alsomay
represent aggressiveness of the tumor. Additionally, bowing or dis-
placement of adjacent vessels may provide insight to the degree
of mass effect from the tumor or surrounding edema. Vessel cal-
iber may contribute in understanding chronicity of tumor growth.
Multiple large caliber feeding vessels may indicate a slower long-
standing progressive growth. A very important element of tumor
vascular architecture is anastomosis. A complete understanding
of vessel anastomoses associated with the tumor supply is critical
in embolization planning to avoid unintended sacriﬁce of sup-
ply to important structures. Figure 1 shows angiograms from
a case of embolization treatment for a juvenile nasopharyngeal
angioﬁbroma (JNA). A Vidian artery is noted with anterograde
opaciﬁcation from the left internal carotid artery to the tumor.
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Table 1 | External carotid arteries, associated cranial nerves, and notable anastomoses.
Artery CN at risk (notable supply pathway) Notable anastomoses
Superior thyroid X, superior laryngeal nerve branch (superior laryngeal artery) Contralateral superior thyroid and inferior thyroid arteries
Lingual XII, extra-cranial segment (multiple branches depending on
regional hemodynamic balance)
Contralateral lingual artery, superior thyroid artery
Facial Rare direct CN association Lingual artery, ophthalmic artery, rarely with ascending
pharyngeal
Ascending
pharyngeal
IV (via MHT), V, VI (jugular br. and via MHT), VII, VIII, IX (jugular br.),
X (jugular br.), XI (jugular br. and musculospinal br.), XII
(hypoglossal br.)
ICA, VA, MHT, middle meningeal artery, inferior tympanic
artery
Posterior auricular VII (stylomastoid br.) Meningeal anastomoses with MMA and ascending
pharyngeal
Occipital VII (stylomastoid br.) Trans-osseous to posterior fossa, muscular branches toVA
Internal maxillary III (via ILT), V (artery of foramen rotundum), VI (via ILT) ICA (via Vidian artery and ILT), ophthalmic artery
Middle meningeal V (cavernous br.), VI, VII (petrous br.) Recurrent ophthalmic to eye and ICA, ILT
Superﬁcial temporal Rarely via anastomoses to VII and VIII. Ophthalmic artery via the supraorbital branch
CN, cranial nerve; ICA, internal carotid artery; VA, vertebral artery; MHT, meningo-hypophyseal trunk; ILT, infero-lateral trunk; br, branch.
FIGURE 1 | Angiogram from a patient with a juvenile nasopharyngeal
angiofibroma (JNA) demonstrating subtle anastomosis between the
external and internal carotid arteries via theVidian artery.The left
internal maxillary artery (white arrow) supplies a JNA as demonstrated by
the left external carotid artery (ECA) injection (A) and the left internal
carotid artery (ICA) injection with reﬂux (B). A Vidian artery is noted (white
arrowheads) in the early arterial phase left ICA injection on lateral (B) and
anteroposterior (C) injections. Faint opaciﬁcation of the tumor arises from
the Vidian artery in the capillary phase of the same ICA injection (D).
Post-embolization ECA injection (E) demonstrates complete
devascularization. Post-embolization, the Vidian artery opaciﬁcation is
attenuated (F).
After embolization, the Vidian artery communication is occluded
distally and opaciﬁcation becomes attenuated. This case illustrates
the need for careful embolization of the left external carotid arter-
ies given the possibility of particle material embolizing through
the Vidian artery into the intra-cranial left ICA circulation.
In addition to architecture, blood ﬂow patterns can be impor-
tant. The rate of tumor opaciﬁcation can be used to characterize
the tumor demand. Higher demand tumors may be more sus-
ceptible to congestion after embolization, and additionally this
feature may be important in surgical planning to reduce blood
loss. Intra-tumoral shunting is also important in embolization
planning. Embolization techniques will need to be tailored to the
degree of venous shunting to avoid unintended embolic material
migration or distal embolization into the venous system.
PERTINENT VASCULAR ANATOMY OF HEAD AND NECK
TUMORS
Branches of the external carotid artery are invariably involved with
extra-cranial tumors and extra-axial intra-cranial tumors, mainly
meningiomas.Middlemeningeal and accessorymeningeal arteries
arising from the internalmaxillary artery supply themeninges over
the frontal, parietal, and temporal lobes. Trans-osseous branches
of occipital arteries may also be recruited for large meningiomas.
Posterior meningeal branches arising from the vertebral artery
may supply the meningiomas of the posterior fossa. The ante-
rior falcine artery arising from the ophthalmic artery may feed
the parafalcine meningiomas located anteriorly. Olfactory groove
meningioma may derive blood supply from bilateral ethmoidal
arteries.
Nasopharyngeal tumors such as JNA and paragangliomas may
derive blood supply from branches of the external carotid artery,
speciﬁcally the sphenopalatine arteries. Paragangliomas such as
glomus jugulare and carotid body tumors may be sustained by
branches of the ascending pharyngeal artery. Tympanic para-
gangliomas and schwannomas are supplied by branches of the
ascending pharyngeal, occipital,middle meningeal arteries, as well
as the extra-cranial branches of the vertebral artery.
Large tumors may “parasitize” nearby vasculature or pre-
existing anastomotic connections may undergo dramatic enlarge-
ment due to ﬂow demand. Olfactory groove or temporal tip
meningiomas may derive blood supply from branches of the
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internal carotid artery such as meningo-hypophyseal trunk or the
superior hypophyseal artery. Tumors of nasopharynx may recruit
internal carotid artery branches including the infero-lateral trunk
or vidian artery. Similarly, tumors of the middle or cerebello-
pontine angle may be supplied by branches of the anterior inferior
cerebellar artery.
Internal carotid artery supply is less common, but may play an
important role in vascular supply through branches including the
ophthalmic artery and ethmoidal branches, infero-lateral trunk,
meningo-hypophyseal trunk, and mandibulovidian arteries.
PRINCIPLES OF EMBOLIZATION
Tumor embolization will devascularize the tumor and can be used
adjunctively with surgical resection or as a palliative measure.
Optimal embolization results in tumor devascularization with no
visualization of intra-tumoral opaciﬁcation while avoiding unin-
tended vessel occlusion. Pre-operative tumor embolization for
hypervascular neoplasms results in improved surgical outcome,
reduced intraoperative blood loss, and facilitates tumor resection
(Zahringer et al., 2005). The following guidelines are suggested
as indications for tumor embolization: (1) to control surgically
inaccessible arterial feeders, (2) to decrease surgical morbidity by
reducing blood loss, (3) to shorten the operative procedure time,
(4) to increase the chances of complete surgical resection, (5) to
decrease the risk of damage to adjacent normal tissue, (6) to relieve
intractable pain, (7) to decrease expected tumor recurrence, and
(8) to allow better visualization of the surgical ﬁeld with decreased
overall surgical complication (American Society of Interventional
and Therapeutic Neuroradiology, 2001).
A thorough understanding of the vessel supply, hemodynamic
characteristics, venous outﬂowpatterns, and anastomoses is essen-
tial for safe and effective treatment.A strong knowledge of regional
vascular anatomy is important as complex vascular variations can
often be encountered in head and neck tumors. All possible anas-
tomoses should be comprehensively explored prior to emboliza-
tion. Particular focus should be placed on identifying ECA to
ICA anastomoses that carry potential for devastating unintended
intra-cranial embolization.
Embolization approaches include transarterial, direct punc-
ture, and a combination of these methods. Ideal tumor emboliza-
tion is achieved with occlusion of the very small vessels within a
tumor, while sparing supply to normal adjacent tissue. Liquid and
particulate embolic materials are effective in penetrating small
vessels, and meticulous use of these materials is essential in pre-
venting unintended occlusions. Common practice is to begin with
smaller sized embolic material to target small distal vessels and
gradually increase particle size in successive injections of embolic
material. If blood supply to cranial nerves is suspected, provoca-
tive testing can be performed by injecting lidocaine and observing
for neurological deﬁcit. If a deﬁcit is elicited the micro-catheter
can be re-positioned. Positioning the micro-catheter as close as
possible to the tumor bed will help avoid embolization of normal
structures.
Most tumor embolizations are performed via the external
carotid arterial supply. Branches of the internal carotid artery may
supply the tumor but in most instances risk of embolization of
these branches may exceed beneﬁt. Time to surgical resection after
embolization may vary depending on tumor type, characteristics,
and degree of devascularization. Embolization is often performed
within 24–48 h of expected surgical resection. Some data suggest
that optimal necrosis for meningiomas requires a longer period
of up to 7–9 days after embolization (Kai et al., 2002). Delay in
surgical resection may cause swelling due to tumor necrosis and
compression of adjacent structures.
EMBOLIZATION MATERIALS
The unique characteristics of each embolic material offer several
options for tumor devascularization (Table 2). Commonly used
embolization materials include poly vinyl alcohol (PVA) particles
of varying sizes as well as pledgets of gelatin sponge (Gelfoam,
Pﬁzer, New York, NY, USA) and microﬁbrillar collagen. Liquid
embolization agents include, n-butylcyanoacrylate (nBCA; Truﬁll
nBCA Liquid Embolic, Codman Neurovascular Inc., Raynham,
MA, USA), ethyl vinyl alcohol polymer (Onyx, eV3 Endovascular
Inc., Irvine, CA,USA), and ethanol. Occlusion of large vessels may
require use of either pushable or detachable coils.
PARTICLES
POLYVINYL ALCOHOL
Polyvinyl alcohol particles are embolic agents available in various
sizes ranging from 45μm to over 1000μm. Use of PVA particles
of 45–150μm followed by 150–250μm can be successful in tumor
embolization. Smaller particles 45–150μm penetrate the capillary
vascular bed of the tumor and aid in devascularization. These par-
ticles often devascularize to the extent that the tumor undergoes
necrosis. Larger particles 150–250μm embolize smaller arterioles
in the tumor bed. If a dangerous anastomosis is suspected, larger
particle sizes can be utilized to prevent accidental embolization of
Table 2 | Commonly used embolic materials and characteristics.
Embolic agent Advantages Limitations
PARTICLES
PVA Microvasculature penetration Radiolucent
Easy to use Irregular shapes may
allow recanalization
Microspheres Microvasculature penetration Fragile
Minimal clumping Many are radiolucent
Gelfoam Medium to large vessel
occlusions
Temporary
Inexpensive, easy to use
LIQUIDAGENTS
nBCA Rapid solidiﬁcation and
occlusion
Rapid solidiﬁcation
Can ﬂow into complex
angioarchitecture
Catheter retainment
Onyx Slower solidiﬁcation Catheter retainment
Can ﬂow into complex
angioarchitecture
COILS
Coils Precise deployment Possible dislodgement
and embolization
Useful in high-ﬂow vessels
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the anastomosing branches. Good blood ﬂow should be ensured
during embolization as anterogradeﬂow in the supplying branches
will carry the embolizing material to the target vasculature. Swift
sequential injections with minimal delay in syringe changes are
important to provide a near continuous and steady administration
of particles because occlusion relies partly on particle aggregation.
Flow arrest due to vasospasm or any other etiology may lead to
reﬂux and increased risk of embolization of an unintended target.
Use of small particles should be limited to the tumor bed as it
may cause necrosis of the overlying skin in cases of extra-cranial
tumors. Embolization should be continued until tumor blush dis-
appears or there is prolonged contrast stagnation with increased
resistance to further embolization. Tumors deriving blood supply
from multiple feeders will require embolization through each of
the supplying pedicles.
MICROSPHERES
Microsphere embolics include trisacryl gelatin microspheres
(Embospheres; BioSphere Medical, Inc., Rockland, ME, USA) and
a newer hydrogel microsphere with a polymer coating (Embozene;
CeloNova BioSciences, Inc., Newnan, GA, USA). These agents are
non-absorbable, round, embolic agents with precise size. These
agents differ from PVA particles due to uniform size and shape,
which theoretically improves distal penetration. The hydrophilic
coating of the Embosphere is intended to reduce aggregation and
facilitates injection through micro-catheters. They are available in
sizes ranging from 40μm to 1300μm. Varying sizes of embolics
have shown to correlate with vessel size and may allow for identi-
ﬁcation of a threshold for intra-tumoral penetration of embolics
(Laurent et al., 2005).A prospective comparison of trisacryl gelatin
microspheres and PVA particles for meningioma embolization
reported reduced blood loss at resection and more distal vessel
penetration with use of trisacryl gelatin microspheres (Bendszus
et al., 2000).
GELFOAM
Gelfoam is awater-insoluble,porous,andpliable agent that resorbs
completely within 4–6weeks. Occlusion occurs after the gelfoam
matrix facilitates thrombus formation. This agent can be used
for embolization of highly vascular head and neck tumors for
pre-operative resection to reduce blood loss. Both sponge and
powder forms have been used in head and neck tumor emboliza-
tion (Rutka et al., 1985). Gelfoam strips are rolled into a cylindrical
shape and advanced through a catheter to the intended location.
The Gelfoam powder is injected through a micro-catheter using a
similar technique as particle embolism.
LIQUID EMBOLIC AGENTS
N -BUTYLCYANOACRYLATE
N-butylcyanoacrylate is a liquid which polymerizes in the ionic
and high pH environment in the body. A mixture of nBCA and
ethiodol is prepared and micronized tantalum powder (Truﬁll;
Codman Neurovascular, Inc., Raynham, MA, USA) can be added
to increase radiopacity for enhanced visualization. It is a good
embolic agent for embolizing branches 0.5mm or greater. It may
not penetrate the tumor bed due to rapid polymerization upon
contact with the blood and therefore an appropriate dilution is
FIGURE 2 | A right external carotid artery injection (A,B) demonstrates
a hypervascular, dural-based, left frontal parasagittal tumor consistent
with a meningioma. An anteroposterior view of a selective right middle
meningeal artery injection shows characteristic features including a
prominent core vascular supply with a sunburst appearance (C) and a
homogenously intense and prolonged vascular stain (D). A right external
carotid artery injection (E,F) performed after PVA particle embolization
demonstrates successful devascularization of middle meningeal artery
supply to the meningioma.
necessary for effectiveness. This will often demand a dilute prepa-
ration of nBCA, however care must be exercised in evaluating
the ﬂow dynamics because polymerization time will be extended
which could lead to unintended embolization. Embolization of
pedicles supplying the tumor can be performedby injecting nBCA.
If more than one feeder is present, each of the pedicles would
need to be treated separately. Such an embolization approach
may be useful in tumors with intra-tumoral shunting in which
particle embolization may lead to transmission of particles to
the venous system and resulting unintended distal embolization.
Furthermore, if large pedicles are embolized, surgical resections
should follow in the ensuing days. Delay in resection may lead to
angiogenesis and growth of new vascular pathways to the tumoral
bed. Embolization of vascular tumors with nBCA has been asso-
ciated with devascularization rates of up to 90–95% (Gupta et al.,
2007).
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ETHYL VINYL ALCOHOL POLYMER (ONYX)
Onyx is a liquid embolic agent dissolved in dimethyl sulfoxide
(DMSO). Upon contact with the blood, DMSO diffuses out and
EVOH polymerizes. This polymer hardens on the outer surface
ﬁrst gradually polymerizing toward the core over several min-
utes. This property allows longer injections of this material. Using
this technique, onyx can be used to embolize tumor bed. This
liquid embolic agent can penetrate the tumor bed and can pro-
vide controlled embolization of the tumor vascular bed with good
penetration. Percutaneous embolization with onyx has also been
described.
COILS
Pushable and detachable coils can be used to embolize large
(>1.5mm) feeders to tumorbeds.Coils afford control and are least
likely to embolize distally into the draining veins. They can be an
ideal embolization solution for tumors with intra-tumoral shunt-
ing. Detachable coils provide more control and can be adjusted
during deployment. Coils with bio-active components can pro-
vide a nidus for thrombosis and eventual occlusion of the vessel.
As with nBCA embolization, coils provide proximal occlusion of
the blood supply to the tumor bed without the embolization of the
tumor vasculature itself. Therefore, surgical resection should fol-
low coil embolization to minimize the development of collateral
blood channels.
ENDOVASCULAR CONSIDERATIONS IN SELECTED TUMORS
The vascular architecture of head and neck tumors can vary con-
siderably resulting in characteristic angiographic ﬁndings. Famil-
iarity with the angioarchitecture of various hypervascular neo-
plasms of the head and neck can improve embolization planning
and success. Careful consideration needs to be given to arterial
supply of vital intra-cranial structures and cranial nerves, as well
as anastomoses.
MENINGIOMA
Meningiomas are usually benign intra-cranial or spinal canal
tumors characterized by dural attachment, slow growth, and high
vascularity. Presentation may be incidental or include headache,
focal symptoms related to mass effect, or seizures. There is an
increased incidence with age. Locations commonly include the
cerebral convexities, falx, and sphenoidal ridges (Kizana et al.,
1996). Angiographic characteristics include a well-circumscribed,
highly vascularized mass with a homogenously intense, and pro-
longed vascular stain (Figure 2). A dual vascular supply with dural
artery supply to the core and pial artery supply to the periphery
may be evident. Enlarged dural arteries may give the appearance
of a sunburst or spoke-and-wheel pattern. Pre-operative endovas-
cular embolization for meningiomas is a useful adjunct to tumor
resection (Figure 3; Richter and Schachenmayr, 1983). Deﬁni-
tive meningioma treatment commonly involves surgical resection,
FIGURE 3 | Contrast enhanced MRI images of a middle cranial fossa meningioma obtained before (A) and after (B) endovascular tumor embolization
with PVA particles demonstrate devascularization.
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however single modality treatment with only embolization has
been reported with tumor shrinkage and clinical improvement
in a small series with short-term follow-up (Bendszus et al.,
2003). Embolization success will depend on anatomic limitations
as well as embolic material. Limitations in achieving complete
embolization have involved inaccessible feeding vessels by micro-
catheter approach and inability to achieve safe superselective
micro-catheter positioning to prevent reﬂux of embolic material
into neighboring branches (Gruber et al., 2000). The optimal time
interval between embolization and surgical resection is not well
deﬁned. A 7–9 day interval has been suggested to allow for opti-
mal necrosis, devascularization, and tumor softening to facilitate
resection, however common practice includes surgical resection
within 48 h of embolization (Kai et al., 2002). When absorbable
embolic material is used this interval is shortened to prevent
recanalization.
HEMANGIOPERICYTOMA
Hemangiopericytomas are rare tumors derived from smoothmus-
cle pericyte cells around the capillaries of the meninges and there-
fore were previously termed angioblastic meningiomas (Yousem
and Robert, 2010). They are considered to be more aggressive
than meningiomas with rates of local recurrence and extra-cranial
metastasis around 30% (Fountas et al., 2006). Clinical presenta-
tion varies based on tumor location and may present similarly to a
meningioma. Angiographic appearance usually includes relatively
few larger vessels with multiple tiny corkscrew-like feeding vessels
entering the tumor mass (Figure 4; Marc et al., 1975). An intense
ﬂuffy vascular stain with associated lingering contrast of venous
channelsmaybe evident. Treatment includes resection and gamma
knife surgery (Olson et al., 2010). Pre-operative embolization is
used primarily as a method of devascularization to facilitate sur-
gical resection (Chin et al., 1993). Reports in the literature can
be elusive due to alternative terminology including angioblastic
meningioma and clustering within reports as angioblastic-type
meningiomas.
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA
Juvenile nasopharyngeal angioﬁbroma is a highly vascular tumor
thought to arise from embryonic ﬁbro-cartilage, which may
present with nasal obstruction and epistaxis in young males.
Surgical resection is the deﬁnitive therapy for JNA. Temporary
intraoperative external carotid artery clamping during resection
has been reported, however pre-operative embolization is widely
accepted to reduce intraoperative bleeding and facilitate resection
(Ahmad et al., 2008). Angiographic appearance includes a charac-
teristic reticulated pattern in the early arterial phase, with a dense,
homogenous blush persisting into the venous phase (Figures 5
and 6). Supply is often from the distal internal maxillary artery
branches, accessory meningeal, and ascending pharyngeal. The
FIGURE 4 | A left internal carotid artery injection demonstrates a highly
vascular mass in the region of the anterior cranial fossa predominantly
supplied by dural branches from the left ophthalmic artery and branches
of the anterior cerebral artery and characteristics consistent with a
hemangiopericytoma (A–C).Tumor supply involves relatively few larger
vessels with extensive penetration by small branching vessels. Magnetic
resonance imaging with contrast shows an enhancing, dural-based, bifrontal
mass in the anterior cranial fossa (D,E). The origin of vessel supply from the
ophthalmic arteries limited the ability to safely embolize the tumor. Partial
pre-operative devascularization was achieved with 45–150 and 150–250μm
PVA particles injected into distal left ophthalmic artery branches supplying the
tumor (F). Pathology conﬁrmed hemangiopericytoma.
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FIGURE 5 | An MRI brain demonstrates a nasal cavity lesion consistent
with a juvenile nasopharyngeal angiofibroma (JNA; arrows;A,B). Left
external carotid angiogram with anteroposterior (C) and lateral (D) projections
demonstrate a hypervascular lesion (arrows) within the left nasopharyngeal
region with predominant blood supply from the artery of the pterygoid canal
and posterior nasopharyngeal branches of the distal internal maxillary artery.
distal internal carotid artery must also be visualized which may
show cavernous carotid supply and reveal skull base invasion. A
systematic approach has been described and involves embolization
of themaxillary artery ﬁrst to offer the best chance of devasculariz-
ing the tumor, followed by selective catheterization and emboliza-
tion of residual vessels (Davis, 1987). Bilateral embolization may
also be necessary if contralateral supply is present. In addition to
embolic complications, post-operative low-grade fever and pain
in the scalp and face are recognized adverse events associated with
JNA (Palmer, 1989).
PARAGANGLIOMA
Paragangliomas are slow growing tumors of the glomus bodies,
which serve as chemoreceptors, and are classiﬁed as neuroen-
docrine tumors. These are most commonly located along the
carotid body, jugular foramen, the vagus nerve, and within the
middle ear. These may present with swallowing difﬁculties or
hearing loss and tinnitus and occur around the seventh or eighth
decade of life. Angiographically, these tumors are characterized by
a hypervascular mass with an intense tumor blush (Figure 7). The
treatment goal is often complete surgical resection. Pre-operative
embolization has been described as adjuvant therapy in these
highly vascularized tumors and has been recognized as a method
to reduce blood loss and shorten operative time (Tikkakoski et al.,
1997). Arterial supply to these structures will vary on location.
Commonly involved arteries include the ascending pharyngeal,
occipital, posterior auricular, and lingual arteries, while there may
rarely be arterial supply from the deep cervical artery and the thy-
rocervical trunk (van den Berg et al., 2000). Vasa nervorum supply
from the involved arteries poses a risk of complication and a lido-
caine challenge may be helpful in identifying vulnerable cranial
nerves. Embolization may be achieved with particle embolization
or Onyx.
COMPLICATIONS
Complications from endovascular embolization include unin-
tended occlusion from embolicmaterial that can result from reﬂux
of liquid embolic material and small particle size. Temporary bal-
loon occlusion can be used as a technique to control placement
of embolic material. Particle size must be chosen appropriately to
allow for controlled delivery and catheter placement must be dis-
tal to origins of vessels to be preserved. Cranial nerve palsies may
result from ischemia to the vasa nervorum and can be reduced
with awareness of potentially harmful anastomoses (Table). Major
complications include blindness fromophthalmic artery occlusion
and ECA to ICA anastomosis emboli resulting in stroke. Minor
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FIGURE 6 | Continued from Figure 5. After superselective embolization
with 45–150μm and 350–500μm PVA particles, a left external carotid
angiogram in anteroposterior (A) and lateral (B) projections demonstrates
attenuated contrast opaciﬁcation of the lesion (black arrows). Two pushable
coils were then deployed into the distal internal maxillary artery [white
arrows, anteroposterior (C) and lateral (D) projections] to complete
embolization of the lesion.
adverse events include facial pain resulting from ischemia and
can be managed with appropriate analgesia. Bradycardia from
a trigeminocardiac reﬂex has been reported in association with
manipulation of the external carotid artery branches, which likely
involves trigeminal nerve afferent tracts to the vagus nerve (Lv
et al., 2007). This has also been reported with internal maxil-
lary artery embolization. Atropine should be available for severe
bradycardia.
INTRA-ARTERIAL CHEMOTHERAPY FOR HEAD AND NECK
TUMORS
Intra-arterial chemotherapy administration could theoretically
offer the ability to deliver higher concentrations of pharmaco-
logic agents than would be allowed through an intravenous route
and thereby limit systemic toxic side-effects. Superselective micro-
catheterization of head and neck arterial supply is technically pos-
sible for delivery of these agents. Several trials have demonstrated
feasibility of this method for adjunctive tumor treatment, however
FIGURE 7 | Anteroposterior projection of a left common carotid artery
injection demonstrates a large hypervascular tumor at the carotid
bifurcation consistent with a paraganglioma. Characteristics including
splaying of the internal and external carotid arteries (A) and intense tumor
blush (B) are shown. Arterial supply includes branches of the ascending
pharyngeal artery (arrow) arising from a common pharyngo-occipital trunk
(not shown) that originates from the internal carotid artery.
survival beneﬁt has not been demonstrated and catheter-related
complications and long-term effects of neurotoxicity have not
been clearly deﬁned (Robbins and Homma, 2008; Robbins et al.,
2010). Efforts in nanotechnology research have been explored,
speciﬁcally using nanoparticle albumin-bound paclitaxel, to more
safely deliver high concentrations of intra-arterial chemotherapy,
however these agents remain investigational (Damascelli et al.,
2007). Alternative methods of improved antineoplastic agent
delivery have been explored in systemic administration includ-
ing molecular targeting and gold nanoparticles as well as gene
therapy, and these methods may be augmented with intra-arterial
administration.
CONCLUSIONS
Endovascular embolization for head and neck tumors can provide
an effective adjunctive therapy to resection. A thorough under-
standing of the angioarchitecture of head and neck tumors and
neurovascular anastomoses can play an important role in diagno-
sis and treatment planning. Novel techniques and embolic agents
will continue to advance endovascular treatment, and emerging
approaches including intra-arterial chemotherapymay expand the
endovascular options for cancer therapy.
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